{"ast":null,"code":"/**\n * Medical Conditions Data\n * Contains information about various infectious diseases and their treatment protocols\n * This data is used throughout the application for displaying condition details\n */\n\nconst medicalConditions = [{\n  id: 'bloodstream_infection',\n  category: 'Bloodstream',\n  name: 'Uncomplicated Bloodstream Infection',\n  commonPathogens: ['S. aureus (MSSA/MRSA)', 'Enterococcus faecalis', 'E. coli', 'Pseudomonas aeruginosa'],\n  empiricTherapy: {\n    'MSSA': 'Cefazolin OR Oxacillin OR Nafcillin',\n    'MRSA': 'Vancomycin OR Linezolid OR Daptomycin',\n    'Enterococcus': 'Ampicillin (E. faecalis) OR Vancomycin (E. faecium)',\n    'Gram-negative': 'Based on susceptibility testing'\n  },\n  duration: '14 days from first negative blood culture (S. aureus), 7 days (Enterococcus, Gram-negatives)',\n  keyPoints: ['Defined as ≤3 days bacteremia in non-neutropenic host', 'No complex source (endocarditis, osteomyelitis)', 'Vascular catheter removal recommended for persistent bacteremia', 'Duration based on active therapy regardless of catheter removal'],\n  clinicalPearls: ['Early transition to oral antibiotics possible for uncomplicated gram-negative bacteremia', 'Monitor for source control and hemodynamic stability', 'Consider MRSA risk factors and local prevalence']\n}, {\n  id: 'osteomyelitis',\n  category: 'Bone/Joint',\n  name: 'Acute Hematogenous Osteomyelitis',\n  commonPathogens: ['S. aureus', 'Streptococcus pyogenes', 'Kingella kingae'],\n  empiricTherapy: {\n    'Mild-Moderate': 'Cefazolin OR Oxacillin OR Nafcillin',\n    'Severe (Low MRSA)': 'Cefazolin OR Oxacillin OR Nafcillin',\n    'Severe (High MRSA)': 'Vancomycin'\n  },\n  duration: '3-4 weeks',\n  keyPoints: ['Kingella not effectively treated by clindamycin', 'Early switch to oral route recommended with clinical improvement', 'Chronic osteomyelitis requires more prolonged treatment'],\n  clinicalPearls: ['Consider combination therapy (vancomycin + oxacillin) for severe sepsis', 'MRI is gold standard for diagnosis', 'Blood cultures positive in 50-60% of cases']\n}, {\n  id: 'meningitis',\n  category: 'CNS',\n  name: 'Bacterial Meningitis (Non-neonates)',\n  commonPathogens: ['S. pneumoniae', 'N. meningitidis', 'H. influenzae'],\n  empiricTherapy: {\n    'Empiric Treatment': 'Ceftriaxone PLUS Vancomycin'\n  },\n  duration: 'S. pneumoniae: 10-14 days, H. influenzae: 7-10 days, N. meningitidis: 5-7 days',\n  keyPoints: ['Vancomycin added for possible resistant S. pneumoniae', 'Dexamethasone beneficial for H. influenzae meningitis', 'Consider acyclovir for concurrent encephalitis', 'Longer courses needed for parenchymal brain infection'],\n  clinicalPearls: ['Lumbar puncture before antibiotics when possible', 'Blood cultures positive in 50-80% of cases', 'Steroid therapy reduces hearing loss in Hib meningitis']\n}, {\n  id: 'pneumonia',\n  category: 'Respiratory',\n  name: 'Community-Acquired Pneumonia',\n  commonPathogens: ['S. pneumoniae', 'Mycoplasma pneumoniae', 'S. pyogenes', 'S. aureus', 'Respiratory viruses'],\n  empiricTherapy: {\n    'Outpatient': 'Amoxicillin OR Ampicillin OR Penicillin',\n    'Inpatient': 'Ceftriaxone (high PCN-resistant regions)',\n    'Atypical Coverage': 'Add macrolide if Mycoplasma suspected',\n    'MRSA Coverage': 'Add Vancomycin OR Clindamycin if suspected'\n  },\n  duration: '5 days for uncomplicated CAP with resolution of fever/tachypnea',\n  keyPoints: ['Respiratory viruses cause majority of CAP in young children', 'Early switch to oral route encouraged', 'Transient S. pneumoniae bacteremia doesn\\'t warrant prolonged IV therapy'],\n  clinicalPearls: ['Consider S. aureus superinfection with influenza', 'Atypical pathogens more common in school-age children', 'Pleural effusion may complicate treatment']\n}, {\n  id: 'cellulitis',\n  category: 'Skin/Soft Tissue',\n  name: 'Cellulitis (Non-purulent)',\n  commonPathogens: ['S. pyogenes', 'S. aureus'],\n  empiricTherapy: {\n    'Mild-Moderate': 'Cefazolin OR Oxacillin/Nafcillin OR Cephalexin',\n    'Severe': 'Vancomycin OR Linezolid OR Ceftaroline'\n  },\n  duration: '5-7 days, tailor based on resolution of signs/symptoms',\n  keyPoints: ['Consider MRSA coverage based on local prevalence', 'Necrotizing fasciitis requires surgical débridement', 'May require gram-negative/anaerobic coverage in certain scenarios'],\n  clinicalPearls: ['Elevation and immobilization aid recovery', 'Mark borders to monitor progression', 'Consider deeper infection if not responding to therapy']\n}, {\n  id: 'uti_pyelonephritis',\n  category: 'Genitourinary',\n  name: 'Pyelonephritis',\n  commonPathogens: ['E. coli', 'Klebsiella species', 'Proteus species', 'Enterobacter species'],\n  empiricTherapy: {\n    'Treatment Options': 'Cephalexin OR TMP-SMX OR Ampicillin + Gentamicin OR Ceftriaxone OR Ciprofloxacin'\n  },\n  duration: '7-10 days (hospitalized), 5-10 days (outpatient), 3-5 days (simple cystitis)',\n  keyPoints: ['Drug selection based on local antibiogram', 'Initial short course IV therapy (2-4 days) as effective as longer courses', 'Avoid nitrofurantoin for upper UTI or bacteremia'],\n  clinicalPearls: ['Urine culture essential for complicated UTI', 'Consider imaging for recurrent infections', 'Longer duration may be needed for renal abscess']\n}];\nexport default medicalConditions;","map":{"version":3,"names":["medicalConditions","id","category","name","commonPathogens","empiricTherapy","duration","keyPoints","clinicalPearls"],"sources":["/Users/joshpankin/My Drive/Obsidian/1. Projects/Antibiotic Learning app/src/data/medicalConditions.js"],"sourcesContent":["/**\n * Medical Conditions Data\n * Contains information about various infectious diseases and their treatment protocols\n * This data is used throughout the application for displaying condition details\n */\n\nconst medicalConditions = [\n  {\n    id: 'bloodstream_infection',\n    category: 'Bloodstream',\n    name: 'Uncomplicated Bloodstream Infection',\n    commonPathogens: ['S. aureus (MSSA/MRSA)', 'Enterococcus faecalis', 'E. coli', 'Pseudomonas aeruginosa'],\n    empiricTherapy: {\n      'MSSA': 'Cefazolin OR Oxacillin OR Nafcillin',\n      'MRSA': 'Vancomycin OR Linezolid OR Daptomycin',\n      'Enterococcus': 'Ampicillin (E. faecalis) OR Vancomycin (E. faecium)',\n      'Gram-negative': 'Based on susceptibility testing'\n    },\n    duration: '14 days from first negative blood culture (S. aureus), 7 days (Enterococcus, Gram-negatives)',\n    keyPoints: [\n      'Defined as ≤3 days bacteremia in non-neutropenic host',\n      'No complex source (endocarditis, osteomyelitis)',\n      'Vascular catheter removal recommended for persistent bacteremia',\n      'Duration based on active therapy regardless of catheter removal'\n    ],\n    clinicalPearls: [\n      'Early transition to oral antibiotics possible for uncomplicated gram-negative bacteremia',\n      'Monitor for source control and hemodynamic stability',\n      'Consider MRSA risk factors and local prevalence'\n    ]\n  },\n  {\n    id: 'osteomyelitis',\n    category: 'Bone/Joint',\n    name: 'Acute Hematogenous Osteomyelitis',\n    commonPathogens: ['S. aureus', 'Streptococcus pyogenes', 'Kingella kingae'],\n    empiricTherapy: {\n      'Mild-Moderate': 'Cefazolin OR Oxacillin OR Nafcillin',\n      'Severe (Low MRSA)': 'Cefazolin OR Oxacillin OR Nafcillin',\n      'Severe (High MRSA)': 'Vancomycin'\n    },\n    duration: '3-4 weeks',\n    keyPoints: [\n      'Kingella not effectively treated by clindamycin',\n      'Early switch to oral route recommended with clinical improvement',\n      'Chronic osteomyelitis requires more prolonged treatment'\n    ],\n    clinicalPearls: [\n      'Consider combination therapy (vancomycin + oxacillin) for severe sepsis',\n      'MRI is gold standard for diagnosis',\n      'Blood cultures positive in 50-60% of cases'\n    ]\n  },\n  {\n    id: 'meningitis',\n    category: 'CNS',\n    name: 'Bacterial Meningitis (Non-neonates)',\n    commonPathogens: ['S. pneumoniae', 'N. meningitidis', 'H. influenzae'],\n    empiricTherapy: {\n      'Empiric Treatment': 'Ceftriaxone PLUS Vancomycin'\n    },\n    duration: 'S. pneumoniae: 10-14 days, H. influenzae: 7-10 days, N. meningitidis: 5-7 days',\n    keyPoints: [\n      'Vancomycin added for possible resistant S. pneumoniae',\n      'Dexamethasone beneficial for H. influenzae meningitis',\n      'Consider acyclovir for concurrent encephalitis',\n      'Longer courses needed for parenchymal brain infection'\n    ],\n    clinicalPearls: [\n      'Lumbar puncture before antibiotics when possible',\n      'Blood cultures positive in 50-80% of cases',\n      'Steroid therapy reduces hearing loss in Hib meningitis'\n    ]\n  },\n  {\n    id: 'pneumonia',\n    category: 'Respiratory',\n    name: 'Community-Acquired Pneumonia',\n    commonPathogens: ['S. pneumoniae', 'Mycoplasma pneumoniae', 'S. pyogenes', 'S. aureus', 'Respiratory viruses'],\n    empiricTherapy: {\n      'Outpatient': 'Amoxicillin OR Ampicillin OR Penicillin',\n      'Inpatient': 'Ceftriaxone (high PCN-resistant regions)',\n      'Atypical Coverage': 'Add macrolide if Mycoplasma suspected',\n      'MRSA Coverage': 'Add Vancomycin OR Clindamycin if suspected'\n    },\n    duration: '5 days for uncomplicated CAP with resolution of fever/tachypnea',\n    keyPoints: [\n      'Respiratory viruses cause majority of CAP in young children',\n      'Early switch to oral route encouraged',\n      'Transient S. pneumoniae bacteremia doesn\\'t warrant prolonged IV therapy'\n    ],\n    clinicalPearls: [\n      'Consider S. aureus superinfection with influenza',\n      'Atypical pathogens more common in school-age children',\n      'Pleural effusion may complicate treatment'\n    ]\n  },\n  {\n    id: 'cellulitis',\n    category: 'Skin/Soft Tissue',\n    name: 'Cellulitis (Non-purulent)',\n    commonPathogens: ['S. pyogenes', 'S. aureus'],\n    empiricTherapy: {\n      'Mild-Moderate': 'Cefazolin OR Oxacillin/Nafcillin OR Cephalexin',\n      'Severe': 'Vancomycin OR Linezolid OR Ceftaroline'\n    },\n    duration: '5-7 days, tailor based on resolution of signs/symptoms',\n    keyPoints: [\n      'Consider MRSA coverage based on local prevalence',\n      'Necrotizing fasciitis requires surgical débridement',\n      'May require gram-negative/anaerobic coverage in certain scenarios'\n    ],\n    clinicalPearls: [\n      'Elevation and immobilization aid recovery',\n      'Mark borders to monitor progression',\n      'Consider deeper infection if not responding to therapy'\n    ]\n  },\n  {\n    id: 'uti_pyelonephritis',\n    category: 'Genitourinary',\n    name: 'Pyelonephritis',\n    commonPathogens: ['E. coli', 'Klebsiella species', 'Proteus species', 'Enterobacter species'],\n    empiricTherapy: {\n      'Treatment Options': 'Cephalexin OR TMP-SMX OR Ampicillin + Gentamicin OR Ceftriaxone OR Ciprofloxacin'\n    },\n    duration: '7-10 days (hospitalized), 5-10 days (outpatient), 3-5 days (simple cystitis)',\n    keyPoints: [\n      'Drug selection based on local antibiogram',\n      'Initial short course IV therapy (2-4 days) as effective as longer courses',\n      'Avoid nitrofurantoin for upper UTI or bacteremia'\n    ],\n    clinicalPearls: [\n      'Urine culture essential for complicated UTI',\n      'Consider imaging for recurrent infections',\n      'Longer duration may be needed for renal abscess'\n    ]\n  }\n];\n\nexport default medicalConditions;"],"mappings":"AAAA;AACA;AACA;AACA;AACA;;AAEA,MAAMA,iBAAiB,GAAG,CACxB;EACEC,EAAE,EAAE,uBAAuB;EAC3BC,QAAQ,EAAE,aAAa;EACvBC,IAAI,EAAE,qCAAqC;EAC3CC,eAAe,EAAE,CAAC,uBAAuB,EAAE,uBAAuB,EAAE,SAAS,EAAE,wBAAwB,CAAC;EACxGC,cAAc,EAAE;IACd,MAAM,EAAE,qCAAqC;IAC7C,MAAM,EAAE,uCAAuC;IAC/C,cAAc,EAAE,qDAAqD;IACrE,eAAe,EAAE;EACnB,CAAC;EACDC,QAAQ,EAAE,8FAA8F;EACxGC,SAAS,EAAE,CACT,uDAAuD,EACvD,iDAAiD,EACjD,iEAAiE,EACjE,iEAAiE,CAClE;EACDC,cAAc,EAAE,CACd,0FAA0F,EAC1F,sDAAsD,EACtD,iDAAiD;AAErD,CAAC,EACD;EACEP,EAAE,EAAE,eAAe;EACnBC,QAAQ,EAAE,YAAY;EACtBC,IAAI,EAAE,kCAAkC;EACxCC,eAAe,EAAE,CAAC,WAAW,EAAE,wBAAwB,EAAE,iBAAiB,CAAC;EAC3EC,cAAc,EAAE;IACd,eAAe,EAAE,qCAAqC;IACtD,mBAAmB,EAAE,qCAAqC;IAC1D,oBAAoB,EAAE;EACxB,CAAC;EACDC,QAAQ,EAAE,WAAW;EACrBC,SAAS,EAAE,CACT,iDAAiD,EACjD,kEAAkE,EAClE,yDAAyD,CAC1D;EACDC,cAAc,EAAE,CACd,yEAAyE,EACzE,oCAAoC,EACpC,4CAA4C;AAEhD,CAAC,EACD;EACEP,EAAE,EAAE,YAAY;EAChBC,QAAQ,EAAE,KAAK;EACfC,IAAI,EAAE,qCAAqC;EAC3CC,eAAe,EAAE,CAAC,eAAe,EAAE,iBAAiB,EAAE,eAAe,CAAC;EACtEC,cAAc,EAAE;IACd,mBAAmB,EAAE;EACvB,CAAC;EACDC,QAAQ,EAAE,gFAAgF;EAC1FC,SAAS,EAAE,CACT,uDAAuD,EACvD,uDAAuD,EACvD,gDAAgD,EAChD,uDAAuD,CACxD;EACDC,cAAc,EAAE,CACd,kDAAkD,EAClD,4CAA4C,EAC5C,wDAAwD;AAE5D,CAAC,EACD;EACEP,EAAE,EAAE,WAAW;EACfC,QAAQ,EAAE,aAAa;EACvBC,IAAI,EAAE,8BAA8B;EACpCC,eAAe,EAAE,CAAC,eAAe,EAAE,uBAAuB,EAAE,aAAa,EAAE,WAAW,EAAE,qBAAqB,CAAC;EAC9GC,cAAc,EAAE;IACd,YAAY,EAAE,yCAAyC;IACvD,WAAW,EAAE,0CAA0C;IACvD,mBAAmB,EAAE,uCAAuC;IAC5D,eAAe,EAAE;EACnB,CAAC;EACDC,QAAQ,EAAE,iEAAiE;EAC3EC,SAAS,EAAE,CACT,6DAA6D,EAC7D,uCAAuC,EACvC,0EAA0E,CAC3E;EACDC,cAAc,EAAE,CACd,kDAAkD,EAClD,uDAAuD,EACvD,2CAA2C;AAE/C,CAAC,EACD;EACEP,EAAE,EAAE,YAAY;EAChBC,QAAQ,EAAE,kBAAkB;EAC5BC,IAAI,EAAE,2BAA2B;EACjCC,eAAe,EAAE,CAAC,aAAa,EAAE,WAAW,CAAC;EAC7CC,cAAc,EAAE;IACd,eAAe,EAAE,gDAAgD;IACjE,QAAQ,EAAE;EACZ,CAAC;EACDC,QAAQ,EAAE,wDAAwD;EAClEC,SAAS,EAAE,CACT,kDAAkD,EAClD,qDAAqD,EACrD,mEAAmE,CACpE;EACDC,cAAc,EAAE,CACd,2CAA2C,EAC3C,qCAAqC,EACrC,wDAAwD;AAE5D,CAAC,EACD;EACEP,EAAE,EAAE,oBAAoB;EACxBC,QAAQ,EAAE,eAAe;EACzBC,IAAI,EAAE,gBAAgB;EACtBC,eAAe,EAAE,CAAC,SAAS,EAAE,oBAAoB,EAAE,iBAAiB,EAAE,sBAAsB,CAAC;EAC7FC,cAAc,EAAE;IACd,mBAAmB,EAAE;EACvB,CAAC;EACDC,QAAQ,EAAE,8EAA8E;EACxFC,SAAS,EAAE,CACT,2CAA2C,EAC3C,2EAA2E,EAC3E,kDAAkD,CACnD;EACDC,cAAc,EAAE,CACd,6CAA6C,EAC7C,2CAA2C,EAC3C,iDAAiD;AAErD,CAAC,CACF;AAED,eAAeR,iBAAiB","ignoreList":[]},"metadata":{},"sourceType":"module","externalDependencies":[]}